Pulmonary Arterial Hypertension Caused by AhR Signal Activation Protecting against Colitis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:203 |
|---|---|
| Enthalten in: |
American journal of respiratory and critical care medicine - 203(2021), 3 vom: 01. Feb., Seite 385-388 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hiraide, Takahiro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Drugs, Chinese Herbal |
|---|
| Anmerkungen: |
Date Completed 05.03.2021 Date Revised 26.02.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1164/rccm.202009-3385LE |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316223638 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316223638 | ||
| 003 | DE-627 | ||
| 005 | 20240229152300.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1164/rccm.202009-3385LE |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1306.xml |
| 035 | |a (DE-627)NLM316223638 | ||
| 035 | |a (NLM)33052717 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hiraide, Takahiro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pulmonary Arterial Hypertension Caused by AhR Signal Activation Protecting against Colitis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.03.2021 | ||
| 500 | |a Date Revised 26.02.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Drugs, Chinese Herbal |2 NLM | |
| 650 | 7 | |a Receptors, Aryl Hydrocarbon |2 NLM | |
| 700 | 1 | |a Teratani, Toshiaki |e verfasserin |4 aut | |
| 700 | 1 | |a Uemura, Shizuka |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshimatsu, Yusuke |e verfasserin |4 aut | |
| 700 | 1 | |a Naganuma, Makoto |e verfasserin |4 aut | |
| 700 | 1 | |a Shinya, Yoshiki |e verfasserin |4 aut | |
| 700 | 1 | |a Momoi, Mizuki |e verfasserin |4 aut | |
| 700 | 1 | |a Kobayashi, Eiji |e verfasserin |4 aut | |
| 700 | 1 | |a Hakamata, Yoji |e verfasserin |4 aut | |
| 700 | 1 | |a Fukuda, Keiichi |e verfasserin |4 aut | |
| 700 | 1 | |a Kanai, Takanori |e verfasserin |4 aut | |
| 700 | 1 | |a Kataoka, Masaharu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of respiratory and critical care medicine |d 1994 |g 203(2021), 3 vom: 01. Feb., Seite 385-388 |w (DE-627)NLM074657305 |x 1535-4970 |7 nnns |
| 773 | 1 | 8 | |g volume:203 |g year:2021 |g number:3 |g day:01 |g month:02 |g pages:385-388 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1164/rccm.202009-3385LE |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 203 |j 2021 |e 3 |b 01 |c 02 |h 385-388 | ||